Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177-Reference-Cited by-同舟云学术

Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177

Published:2022-07-13 Issue:7 Volume:14 Page:1526
ISSN:1999-4915
Container-title:Viruses
language:en
Short-container-title:Viruses

Author:

Jäger Niklas,Hoffmann Markus^ORCID,Pöhlmann Stefan^ORCID,Krüger Nadine^ORCID

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...]

Funder

Deutsche Forschungsgemeinschaft

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Link

https://www.mdpi.com/1999-4915/14/7/1526/pdf

Reference30 articles.

1. Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020–2021;Collaborators;Lancet,2022

2. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

3. Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

4. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

5. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

2. Approaches to the Identification of Molecules Altering Programmed Ribosomal Frameshifting in Viruses;Methods and Principles in Medicinal Chemistry;2024-07-05

3. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating;mBio;2024-04-10

4. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating;2023-08-24